引用本文
  • 金佳利综述,刘学源审校.Sigma-1受体与阿尔茨海默病关系的研究进展[J].同济大学学报(医学版),2015,36(5):129-132.    [点击复制]
  • JIN Jia-li,LIU Xue-yuan.Progress of relationship between sigma-1 receptor and Alzheimer' disease[J].同济大学学报(医学版),2015,36(5):129-132.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 402次   下载 448 本文二维码信息
码上扫一扫!
Sigma-1受体与阿尔茨海默病关系的研究进展
金佳利综述,刘学源审校
0
(同济大学附属第十人民医院神经内科,上海 200072)
摘要:
近年来,sigma-1受体在神经系统退行性疾病中已越来越受到关注,人们发现其具有介导细胞分化,神经元保护,促神经再生和延缓记忆减退等作用。本文基于一系列人类疾病动物模型及临床前研究,分析了sigma-1受体的特点及生物学效应,介绍了其在阿尔茨海默病(Alzheimer's disease, AD)发生发展过程中的作用及治疗方面的现状。Aβ对σ-1受体表达调节这一新视点,将成为研究AD发病机制的新方向。
关键词:  sigma-1受体  阿尔茨海默病  β-淀粉样蛋白
DOI:10.16118/j.1008-0392.2015.05.028
投稿时间:2015-02-12
基金项目:国家自然科学基金(81171163);上海市教委重点课题资助项目(14ZZ044)
Progress of relationship between sigma-1 receptor and Alzheimer' disease
JIN Jia-li,LIU Xue-yuan
(Dept. of Neurology, Tenth People's Hospital,Tongji University, Shanghai 200072, China)
Abstract:
The role of sigma-1(σ-1) receptor in neurodegenerative disease has been drawn more and more attentions recently, it has been found that σ-1 receptor involves in cellular differentiation, neuroprotection, neuroplasticity and anti-amnesia of the brain. Based on animal models and preclinical studies of human diseases, this article describes the biological effects and treatment prospects of σ-1 receptor, and related cellular mechanisms of σ-1 receptor in pathogenesis of Alzheimer's disease, particularly the mechanisms of Aβ in σ-1 receptors expression, which would be a new direction for AD pathogenesis.
Key words:  sigma-1 receptor  Alzheimer's disease  amyloid protein β

您是第5110487位访问者
版权所有《同济大学学报(医学版)》编辑部
主管单位:教育部 主办单位:同济大学
地  址: 上海四平路1239号 邮编:200092 电话:021-65980705 E-mail: yxxb@tongji.edu.cn
本系统由北京勤云科技发展有限公司设计